| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $223.4M | — | -26.1% |
| Cost of Revenue | $160.4M | — | -29.0% |
| Gross Profit | $63.0M | — | -17.6% |
| R&D Expense | $3.0M | — | +25.0% |
| SG&A Expense | $50.4M | — | +14.7% |
| Operating Income | $7.1M | — | -73.9% |
| Pre-tax Income | $4.1M | — | -82.3% |
| Income Tax | $2.1M | — | -67.4% |
| Net Income | $2.0M | — | -88.1% |
| EPS (Basic) | -$0.09 | — | -550.0% |
| EPS (Diluted) | -$0.09 | — | -550.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $200.7M | -17.9% | -42.4% |
| Accounts Receivable | $292.3M | +7.6% | +3.5% |
| Inventory | $168.0M | +11.7% | -10.1% |
| Current Assets | $879.4M | +1.2% | -9.9% |
| Total Assets | $1.48B | +1.6% | +3.5% |
| Current Liabilities | $390.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.4M | — | -125.3% |
| Capital Expenditures | $7.5M | — | +219.3% |
| Investing Cash Flow | -$7.5M | — | -219.3% |
| Financing Cash Flow | -$7.6M | — | -341.3% |
| Free Cash Flow | -$36.9M | — | -139.6% |
| -4.4% |
| Long-term Debt | $657.0M | -0.3% | +1.9% |
| Total Liabilities | $1.21B | +1.3% | +9.5% |
| Stockholders' Equity | -$214.4M | -3.9% | -119.3% |